The need to develop personalized interventions to improve cognition in schizophrenia.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Who cites it

16 citing papers in PubMed.

1. How to improve the physical health of people with severe mental illness? A multicentric randomized controlled trial on the efficacy of a lifestyle group intervention.European psychiatry : the journal of the Association of European Psychiatrists · 2021
   Trial
2. Association between serum non-enzymatic antioxidants and cognitive impairment in drug-naïve patients with schizophrenia.BMC psychiatry · 2026
   Article
3. Two structural alteration patterns of the thalamus in patients with schizophrenia.BMC medicine · 2025
   Article
4. Levo-Stepholidine as a Potential Cognitive Enhancer: Insights into Executive Function and Memory Improvements.Biomedicines · 2024
   Article
5. Altered Sex Differences in Hippocampal Subfield Volumes in Schizophrenia.Schizophrenia bulletin · 2024
   Article
6. Cognitive and functional deficits are associated with white matter abnormalities in two independent cohorts of patients with schizophrenia.European archives of psychiatry and clinical neuroscience · 2022
   Article
7. Reappraising the variability of effects of antipsychotic medication in schizophrenia: a meta-analysis.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2022
   Article
8. Social Cognition Individualized Activities Lab for Social Cognition Training and Narrative Enhancement in Patients With Schizophrenia: A Randomized Controlled Study to Assess Efficacy and Generalization to Real-Life Functioning (Prot. n°: NCT05130853).Frontiers in psychiatry · 2022
   Article
9. We Should Improve Personalization of Management in Patients with a Diagnosis of Schizophrenia.Journal of clinical medicine · 2021
   Article
10. Investigating the Relationship between White Matter Connectivity and Motivational Circuits in Subjects with Deficit Schizophrenia: A Diffusion Tensor Imaging (DTI) Study.Journal of clinical medicine · 2021
    Article
11. Mismatch Negativity and P3a Impairment through Different Phases of Schizophrenia and Their Association with Real-Life Functioning.Journal of clinical medicine · 2021
    Article
12. Investigating the Relationships of P3b with Negative Symptoms and Neurocognition in Subjects with Chronic Schizophrenia.Brain sciences · 2021
    Article
13. Improving Knowledge on Pathways to Functional Outcome in Schizophrenia: Main Results From the Italian Network for Research on Psychoses.Frontiers in psychiatry · 2021
    Review
14. Gender Differences in Clinical and Psychosocial Features Among Persons With Schizophrenia: A Mini Review.Frontiers in psychiatry · 2021
    Review
15. Tracing Links Between Early Auditory Information Processing and Negative Symptoms in Schizophrenia: An ERP Study.Frontiers in psychiatry · 2021
    Article
16. Rethinking Schizophrenia and Depression Comorbidity as One Psychiatric Disorder Entity: Evidence From Mouse Model.Frontiers in neuroscience · 2020
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.